Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...
It has been a longstanding challenge to design a platform that enables the switchable capture and release of liquids with ...
In this article, readers will discover the seven packaging innovations—four associated with format and design achievements ...
Guan tang bao soup dumplings are the word-of-mouth draw at a new Rosemead restaurant from the owners of Ji Rong Peking Duck ...
From cleaning essentials to beauty supplies, store aisles are packed with brands competing for your loyalty. Making sense of all the labels and product features can be a challenge, that is, without ...
T.J. Maxx and Marshalls take the cake when it comes to retail therapy—or if you’re just after a really great bargain. Few stores measure up in comparison, but that doesn’t mean shoppers don’t have ...
Did you know that 72% of consumers say packaging design influences their purchasing decisions? In the skincare industry, ...
Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.
Koru Medical Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results